Desensitization Protocol for Rituximab-Induced Serum Sickness

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|9|3|240-242

ISSN： 1574-8863

Source： Current Drug Safety, Vol.9, Iss.3, 2014-11, pp. : 240-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab-Induced Hypersensitivity Pneumonitis

By  

Respiration, Vol. 78, Iss. 2, 2008-10 ,pp. : 225-229

Karger

Access to resources Recommend Favorite

Risk Factors for Rituximab-Induced Interstitial Lung Diseases in Patients with Malignant Lymphoma

By  

Respiration, Vol. 85, Iss. 2, 2012-12 ,pp. : 175-175

Karger

Access to resources Recommend Favorite

TNF‐α antagonist may not be suitable for severe rituximab‐induced interstitial lung disease

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 3, 2015-06 ,pp. : 249-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct and Indirect Rituximab‐Induced T Cell Depletion: Comment on the Article by Mélet et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 4, 2014-04 ,pp. : 1053-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab-Induced Interstitial Pneumonia due to CD8-Positive T Cell Infiltration

By  

Acta Haematologica, Vol. 128, Iss. 2, 2012-06 ,pp. : 107-109

Karger

Access to resources Recommend Favorite